Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Foundation Medicine on a Molecular Level
Personalized Medicine
Videos
— September 28, 2015
Gary Palmer, MD
Cancer is basically a disease of the genome. We know that most cancers are caused by changes at the DNA level, whether it’s caused by radiation, cigarette smoking, or unknown factors. DNA changes are really what drive cancer.
Related Items
Liquid Biopsies on the Horizon for Children With Solid Cancers
By
Ella Ben-Ari
September 2023, Vol 13, No 9
Personalized Medicine
,
Pediatric Cancers
Dual RAF/MEK Inhibitor Shows Promising Activity in Tumors with RAS/RAF Mutations
By
William King
January 2021, Vol 11, No 1
Personalized Medicine
Patient-Centered Clinical Pathways Should Incorporate the Patient’s Voice
By
Chase Doyle
November 2019, Vol 9, No 11
Personalized Medicine
Can Society Afford Not to Personalize Medicine in Oncology?
By
Gail Thompson
October 2015, Vol 5, No 7
Personalized Medicine